Trial intelligence / Profile preview

Adjunctive Methylprednisolone for PCP in Pediatric AIDS

NCT00000741Phase 3Withdrawn

Sponsor
National Institute of Allergy and Infectious Diseases
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of methylprednisolone in Pneumocystis pneumonia (PCP), sponsored by National Institute of Allergy and Infectious Diseases. Status: withdrawn.

02

Drugs

methylprednisolone
03

Conditions

Pneumocystis pneumonia (PCP)

Beyond the preview

Go deeper on NCT00000741.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000741.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call